CCL Industries Announces Q2 Results
By CCL HealthcareCCL's Q2 highlights include:
- Adjusted basic earnings per Class B share of $0.68, up 21.4% earnings per Class B share of $0.63 up 50.0%; currency translation impact nominal
- Sales increased 30.5% supported by 5.7% organic sales growth at CCL and strong first full quarter for CCL Secure
- Checkpoint continued to deliver solid operating results, 11.4% operating margin
- Completed five for one stock split on 5 June, 2017
CCL's six-month highlights include:
- Year-to-date adjusted basic earnings per Class B share of £1.25, up 14.7%; basic earnings per Class B share of $1.13, up 21.5%
- Sales increased 26.7% supported by 6.2% CCL organic sales growth
- Operating income increased 18.5% driven by strong performance at the CCL Segment augmented by acquisitions
For more information, please download this free white paper.